Covered recipient · General Payments record
MARY TAYLOR HYATT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$1,053.05
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $328.30 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $72.95 | 4 |
| Lilly USA, LLC | $61.42 | 3 |
| Corcept Therapeutics | $47.40 | 3 |
| CeQur Corporation | $25.84 | 1 |
| DEXCOM, INC. | $25.49 | 1 |
| SANOFI-AVENTIS U.S. LLC | $24.81 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.22 | 1 |
| Rhythm Pharmaceuticals, Inc. | $23.10 | 1 |
| Insulet Corporation | $23.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $24.22 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086137933 | CMS |
| CeQur Corporation | $25.84 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126847420 | CMS |
| Corcept Therapeutics | $16.79 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117765299 | CMS |
| Corcept Therapeutics | $14.97 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117765339 | CMS |
| Corcept Therapeutics | $15.64 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117765429 | CMS |
| Dexcom, Inc. | $25.49 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153320630 | CMS |
| Insulet Corporation | $23.07 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116822946 | CMS |
| Lilly USA, LLC | $13.48 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135177105 | CMS |
| Lilly USA, LLC | $23.61 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135180255 | CMS |
| Lilly USA, LLC | $24.33 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135180253 | CMS |
| Novo Nordisk Inc | $14.35 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096888388 | CMS |
| Novo Nordisk Inc | $14.14 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097205665 | CMS |
| Novo Nordisk Inc | $20.53 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097200148 | CMS |
| Novo Nordisk Inc | $23.93 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130818328 | CMS |
| Rhythm Pharmaceuticals, Inc. | $23.10 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141480422 | CMS |
| SANOFI-AVENTIS U.S. LLC | $24.81 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139854823 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.